Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning (PHSTT-01)
Diagnostic Performance of Prostate HistoScanningTM (PHS) in Men at Risk of Prostate Cancer Scheduled for an Initial Prostate Biopsy
Sponsor: Advanced Medical Diagnostics s.a.
Terminated
Sponsor is bankrupt
Other Prostate Cancer trials with similar outcome
A PHASE4 clinical study on Prostate Cancer, this trial is terminated or withdrawn. The trial is conducted by Advanced Medical Diagnostics s.a. and has accumulated 6 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Advanced Medical Diagnostics s.a.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Amsterdam, Netherlands , Barcelona, Spain , Blackpool, United Kingdom , Braunschweig, Germany , Bristol, United Kingdom , Brussels, Belgium , Carouge, Switzerland , Cologne, Germany , Düsseldorf, Germany and 21 more locations